PL366451A1 - Osteoprotegeryna z mleka - Google Patents

Osteoprotegeryna z mleka

Info

Publication number
PL366451A1
PL366451A1 PL02366451A PL36645102A PL366451A1 PL 366451 A1 PL366451 A1 PL 366451A1 PL 02366451 A PL02366451 A PL 02366451A PL 36645102 A PL36645102 A PL 36645102A PL 366451 A1 PL366451 A1 PL 366451A1
Authority
PL
Poland
Prior art keywords
milk
osteoprotegerin
present
preparation
composition
Prior art date
Application number
PL02366451A
Other languages
English (en)
Inventor
Karine Vidal
Den Broek Peter Van
Cavin Elizabeth Offord
Anne Donnet-Hugues
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of PL366451A1 publication Critical patent/PL366451A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Animal Husbandry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
PL02366451A 2001-04-03 2002-03-15 Osteoprotegeryna z mleka PL366451A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01108414 2001-04-03

Publications (1)

Publication Number Publication Date
PL366451A1 true PL366451A1 (pl) 2005-02-07

Family

ID=8177040

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366451A PL366451A1 (pl) 2001-04-03 2002-03-15 Osteoprotegeryna z mleka

Country Status (18)

Country Link
US (2) US7749960B2 (pl)
EP (2) EP1377610A2 (pl)
JP (1) JP4921687B2 (pl)
CN (1) CN1500096A (pl)
AT (1) ATE458004T1 (pl)
AU (1) AU2002253133B2 (pl)
BR (1) BR0208554A (pl)
CA (1) CA2442694C (pl)
DE (1) DE60235418D1 (pl)
ES (1) ES2337716T3 (pl)
IL (1) IL158152A0 (pl)
MX (1) MXPA03008895A (pl)
PL (1) PL366451A1 (pl)
PT (1) PT1757619E (pl)
RU (1) RU2324705C2 (pl)
UA (1) UA84831C2 (pl)
WO (1) WO2002081521A2 (pl)
ZA (1) ZA200308490B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US9878003B2 (en) 2006-03-06 2018-01-30 The University Of Manchester Method of treating bone disorders using TSG-6
GB0604460D0 (en) * 2006-03-06 2006-04-12 Isis Innovation Treatment
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2008078588A1 (ja) * 2006-12-25 2008-07-03 National University Corporation Tokyo Medical And Dental University 関節軟骨の変性を治療又は予防するための医薬及び方法
SG10201606949QA (en) 2016-08-19 2018-03-28 Singapore Health Serv Pte Ltd Immunosuppressive composition for use in treating immunological disorders
WO2023007468A1 (en) 2021-07-30 2023-02-02 Helaina, Inc. Methods and compositions for protein synthesis and secretion

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB124309A (en) 1918-04-16 1919-03-27 John Page Croft An Improved Coffee Preparation.
FR2039157A7 (en) 1969-04-14 1971-01-15 Marlan Sl Liquid coffee concentrate
DE3821374A1 (de) 1988-06-24 1990-01-18 Nolde Sylvia Kaffee-bonbons
US4946701A (en) 1989-08-04 1990-08-07 Procter & Gamble Beverages
US5182926A (en) 1991-09-16 1993-02-02 Nestec S.A. Recovery of aroma gases
EP0652889A4 (en) * 1992-06-15 1997-05-07 Gene Pharming Europ Bv PRODUCTION OF RECOMBINANT POLYPEPTIDES BY BOVINE SPECIES AND TRANSGENIC PROCESSES.
GB2285578A (en) 1993-12-22 1995-07-19 Leilani Lea Beverages containing added guaranine
JP3112637B2 (ja) 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JPH08165249A (ja) 1994-12-14 1996-06-25 Snow Brand Milk Prod Co Ltd 骨強化作用を有する組成物
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
JP3578538B2 (ja) 1996-01-09 2004-10-20 雪印乳業株式会社 離乳食
JP3613488B2 (ja) 1996-01-17 2005-01-26 雪印乳業株式会社 栄養補給用組成物
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP3061364B2 (ja) 1996-04-26 2000-07-10 雪印乳業株式会社 乳児用調製乳
JPH1057071A (ja) 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
EP0826308B1 (en) 1996-08-26 2000-12-27 Societe Des Produits Nestle S.A. Coffee extraction process and product
WO1998028423A2 (en) 1996-12-20 1998-07-02 Board Of Regents, The University Of Texas System Compositions and methods of use for osteoclast inhibitory factors
JP3523650B2 (ja) 1997-04-15 2004-04-26 三共株式会社 新規蛋白質及びその製造方法
AU7469998A (en) 1997-05-01 1998-11-24 Amgen, Inc. Chimeric opg polypeptides
AU7705098A (en) 1997-05-29 1998-12-30 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like protein 8
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
DE69834719D1 (de) * 1997-09-24 2006-07-06 Sankyo Co Methode zur diagnose von abnormalem knochenstoffwechsel
US6194151B1 (en) 1997-09-26 2001-02-27 Millenium Pharmaceuticals, Inc. Molecules of the TNF receptor superfamily and uses therefor
JP3933273B2 (ja) 1997-09-30 2007-06-20 雪印乳業株式会社 家畜飼料
US6297022B1 (en) 1997-10-08 2001-10-02 Smithkline Beecham Corporation Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
US6087555A (en) 1997-10-15 2000-07-11 Amgen Inc. Mice lacking expression of osteoprotegerin
US5997929A (en) 1997-11-03 1999-12-07 Nestec S.A. Extraction process
WO1999026977A1 (en) 1997-11-24 1999-06-03 Biogen, Inc. Novel receptors opg-2
JPH11155420A (ja) 1997-12-02 1999-06-15 Snow Brand Milk Prod Co Ltd トランスジェニック動物
CA2316545A1 (en) 1997-12-29 1999-07-08 Regeneron Pharmaceuticals, Inc. Novel nucleic acid and polypeptide with homology to the tnf-receptors
US6093436A (en) 1998-02-04 2000-07-25 Nestec S.A. Beverage antioxidant system
US6149957A (en) 1998-04-09 2000-11-21 Nestec S.A. Aroma recovery process
US6790823B1 (en) * 1998-04-23 2004-09-14 Amgen Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
JP4082782B2 (ja) 1998-04-30 2008-04-30 雪印乳業株式会社 歯周病予防及び改善剤
AU4217499A (en) 1998-05-29 1999-12-13 Adams Food Ltd. Composition having therapeutic and/or nutritionally active substituent
JP2000086697A (ja) 1998-09-10 2000-03-28 Snow Brand Milk Prod Co Ltd 新規蛋白質、その製造法及び用途
HRP20010188A2 (en) 1998-09-15 2002-04-30 Pharmexa As Method for down-regulating osteoprotegerin ligand activity
JP4097335B2 (ja) * 1998-09-30 2008-06-11 生化学工業株式会社 食品添加物
JP2000102390A (ja) 1998-09-30 2000-04-11 Snow Brand Milk Prod Co Ltd Ｄｎａ及びそれを用いた蛋白質の製造方法
WO2000021554A1 (en) 1998-10-09 2000-04-20 Sankyo Company, Limited Preventives or remedies for cachexia
US6916907B1 (en) 1998-10-23 2005-07-12 Curagen Corporation Nucleic acids encoding osteoprotegern-like proteins and methods of using same
WO2000024416A1 (en) * 1998-10-28 2000-05-04 Snow Brand Milk Products Co., Ltd. Remedies for bone metabolic errors
ES2229808T3 (es) 1999-01-28 2005-04-16 Societe Des Produits Nestle S.A. Crema en polvo soluble aromatizada.
US6413558B1 (en) 1999-07-19 2002-07-02 The Proctor & Gamble Co. Compositions, kits, and methods for providing and maintaining energy and metal alertness
AU6946300A (en) * 1999-08-30 2001-03-26 Mayo Foundation For Medical Education And Research Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders
US7794744B2 (en) * 2000-04-18 2010-09-14 Nestec S.A. Nutritional modules

Also Published As

Publication number Publication date
WO2002081521A3 (en) 2003-08-28
ATE458004T1 (de) 2010-03-15
US7524815B2 (en) 2009-04-28
CA2442694A1 (en) 2002-10-17
EP1757619A3 (en) 2007-03-14
UA84831C2 (ru) 2008-12-10
US20040137074A1 (en) 2004-07-15
MXPA03008895A (es) 2005-03-07
US20050288219A1 (en) 2005-12-29
ES2337716T3 (es) 2010-04-28
DE60235418D1 (de) 2010-04-01
BR0208554A (pt) 2004-03-02
EP1757619A2 (en) 2007-02-28
CA2442694C (en) 2012-03-06
RU2324705C2 (ru) 2008-05-20
JP2004537980A (ja) 2004-12-24
IL158152A0 (en) 2004-03-28
AU2002253133B2 (en) 2008-02-28
JP4921687B2 (ja) 2012-04-25
CN1500096A (zh) 2004-05-26
US7749960B2 (en) 2010-07-06
PT1757619E (pt) 2010-03-25
ZA200308490B (en) 2005-01-31
EP1377610A2 (en) 2004-01-07
WO2002081521A8 (en) 2003-10-23
WO2002081521A2 (en) 2002-10-17
RU2003132059A (ru) 2005-05-10
EP1757619B1 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
MY132120A (en) Bone health compositions derived from milk.
BR0214838A (pt) Composição para promoção de crescimento ósseo e manutenção da saúde óssea
MXPA04005582A (es) Alimento o composicion de alimento para mascotas que contiene extracto de plantas para la salud osea.
WO2002060955A3 (en) Modified antibodies and methods of use
IL124798A0 (en) Bioactive load bearing bone bonding compositions
MXPA05004225A (es) Anticuerpos de neutralizacion contra gdf-8, y sus usos.
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
WO2004019884A3 (en) Agents and methods for enhancing bone formation
IL159527A0 (en) Human dr4 antibodies and uses thereof
MY145790A (en) Composition
IL157071A0 (en) Endotoxine binding by lactic acid bacteria and bifidobacteria
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
SI1461054T1 (sl) Pripravki grampozitivnih bakterij za zdravljenje bolezni ki obsegajo imunsko disregulacijo
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
EP1485111A4 (en) COMPOSITIONS WITH LABELS BIOACTIVE MATERIALS AND Mammalian COLOSTRUM, MANUFACTURING PROCESS AND TREATMENT
WO2002078741A3 (en) Methods and compositions for modulating the immune system of animals
IL158152A0 (en) Osteoprotegerin in milk
IL171384A (en) Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
AU2003290031A1 (en) Method of improvement of blood circulation
WO2003024486A1 (en) Remedies for bone loss
UA84832C2 (ru) Остеопротегерин, его применение для изготовления фармацевтической композиции и получения пищевого продукта и корма для животных
MXPA01010449A (es) Composicion y metodo util para el tratamiento del colico.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)